We invited Dr. Ji and Dr. Brunswick back today to continue the discussion about the work that Sorrento Therapeutics (NASDAQ: SRNE) is doing to find a cure for COVID-19.
Dr. Ji is Chairman, President and CEO of Sorrento Therapeutics, and granted us an exclusive interview in our RagingBull Elite chatroom earlier today to discuss Sorrento Therapeutics COVIDTRAP and its early promise as a cure for COVID-19.
Of interest right off the bat is Dr. Brunswick’s remarks about this approach compared to traditional vaccines. And for people who are opposed to vaccines this approach is something they would want to seriously consider, possibly even gravitate towards There’s certainly conversation about this facet of finding a cure globally. Along with any potential cure is an apprehension of getting a vaccination.
“We are not utilizing the basic immune system of the patient to actually act against the virus. When a person is vaccinated, there they introduce a foreign protein or a virus, and then the body’s own immune system reacts to that virus.”
Our host Hitha Herzog pressed the doctors for whether this could be a potential solution for people who are apprehensive of a traditional vaccination.
“Absolutely” said Dr. Brunswick.
Once again this is an illuminating dive into the work of Dr. Ji’s team at Sorrento (they joined us a couple of weeks ago). Today, we went into great detail about the COVIDTRAP approach and its early effectiveness. Dr. Ji and Dr. Brunswick shared;
- Why the COVIDTRAP may actually be more effective against COVID-19 mutations, not less.
- That they have applied for $500M in government funding, and expect a reply about their clinical trials.
- Depending on the dosage used, whether patients may have to “top-up” on the COVIDTRAP antibodies.
- Whether there would be any rejection by the body for this approach.
The doctors answered many of Hitha’s questions about the application of this treatment, and explored a lot of the deeper scientific principles behind the approach.